These results, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the concept of targeting ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Diseases. Observe: Final results may vary about https://davidv581zwt1.blog2news.com/profile